Beijing, China, April 20, 2023 – InnoCare Pharma, a high-tech biopharmaceutical company, announced that its independently developed novel Bruton's···【Read More】
Update: 2026-01-22Source: Haiou HealthViews: 91
Beijing, China – December 31, 2020 – InnoCare Pharma, a high-tech biopharmaceutical company, announced that its independently developed Bruton's t···【Read More】
Update: 2026-01-22Source: Haiou HealthViews: 83
Beijing, China, December 27, 2020 – InnoCare Pharma (Hong Kong Stock Exchange: 09969), a high-tech biopharmaceutical company, announced today that its···【Read More】
Update: 2026-01-22Source: Haiou HealthViews: 77
Hello, osimertinib is a prescription drug. After placing an order with a valid prescription, we can provide compliant mailing service to ensure the sa···【Read More】
Update: 2026-01-22Source: Haiou HealthViews: 75
The price of osimertinib varies by specifications, regions and medical insurance policies. Currently, the price per box ranges from several thousand y···【Read More】
Update: 2026-01-22Source: Haiou HealthViews: 75
Orelabrutinib is a small-molecule targeted drug classified as a Bruton's tyrosine kinase (BTK) inhibitor. It is mainly indicated for the treatment···【Read More】
Update: 2026-01-22Source: Haiou HealthViews: 75
Whether orelabrutinib needs long-term administration depends on the comprehensive evaluation of disease progression, adverse reactions and physicians.···【Read More】
Update: 2026-01-22Source: Haiou HealthViews: 85
Since being included in the medical insurance scheme, Orelabrutinib has seen a substantial price reduction, leading to a marked decrease in out-of-poc···【Read More】
Update: 2026-01-22Source: Haiou HealthViews: 81
Orelabrutinib is a Class 1 innovative drug independently developed by Nuocheng Jianhua, a local biopharmaceutical enterprise in China. As a highly sel···【Read More】
Update: 2026-01-22Source: Haiou HealthViews: 84
Orelabrutinib is a prescription-only medication that can be obtained from hospital pharmacies or qualified medical institutions upon presentation of a···【Read More】
Update: 2026-01-22Source: Haiou HealthViews: 74
The price of orelabrutinib varies by region, specification, medical insurance policy and other factors. Generally, the reference price ranges from app···【Read More】
Update: 2026-01-21Source: Haiou HealthViews: 75
Orelabrutinib (a Bruton's tyrosine kinase [BTK] inhibitor) should not be used in combination with strong CYP3A inhibitors/inducers, anticoagulants···【Read More】
Update: 2026-01-21Source: Haiou HealthViews: 74
On January 16, 2025, Aoyixin® (Liertinib Tablets, Investigational Code: ASK120067), a Class 1 chemical new drug and third-generation EGFR inhibitor, w···【Read More】
Update: 2026-01-21Source: Haiou HealthViews: 78
Liotinib is a targeted therapeutic agent that exerts its anticancer effects primarily by inhibiting specific abnormal proteins or signaling pathways w···【Read More】
Update: 2026-01-21Source: Haiou HealthViews: 83
The price of Liotinib typically ranges from approximately $300 to $800 per box. The exact cost varies significantly depending on factors including dru···【Read More】
Update: 2026-01-21Source: Haiou HealthViews: 76
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH



